¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"order of bond"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maximal surgical blood order schedule=MSBOS
    ÃÖ´ë¼ö¼úÇ÷¾×½Åû·®
  • maximum surgical blood order schedule
    ÃÖ´ë¼ö¼úÇ÷¾×¿äû¿¹Á¤Ç¥
  • mixed order reaction
    È¥ÇÕÂ÷¹ÝÀÀ(ûèùêó­ Úãëë).
  • order disorder
    Áú¼­¹«Áú¼­(òñßíÙíòñßí).
  • order of perturbation
    ¼·µ¿ÀÇ Â÷¼ö(àîÔÑ¡­ó­ â¦).
  • order of reaction
    ¹ÝÀÀÂ÷¼ö(Úãëëó­â¦).
  • ovocyte of first order
    ¹Ì¼÷¶õ(Ú±âÙÕ°).
  • partial order
    ¹Ý¼ø¼­(Úââ÷ßí).
  • rank order
    ¼øÀ§(ËàËô).
  • rank order
    ¼øÀ§(â÷êÈ)
  • second order neuron
    Á¦ÀÌ´º¿ì·Ð.
  • second order neuron
    Á¦ÀÌ´º¿ì·Ð.
  • second order reaction
    ÀÌÂ÷¹ÝÀÀ.
  • third order neuron
    Á¦»ïÂ÷½Å°æ´ÜÀ§(ð¯ß²ó­ãêÌèÓ¤êÈ).
  • zero order
    ¿µÂ÷(çÍó­)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • electrostatic bond
    Á¤Àü±â °áÇÕ(ð¡ï³Ñ¨Ì¿ùê)
  • energy-rich bond
    ºÎ(Ý£)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • equatorial bond
    ¼öÆò¹æÇâ °áÇÕ (â©øÁÛ°ú¾Ì¿ùê)
  • exocyclic bond
    °í¸®¹Û °áÇÕ(Ì¿ùê)
  • glycosidic bond
    ±Û¶óÀÌÄÚ»çÀÌµå °áÇÕ(Ì¿ùê)
  • heterologous bond
    À̺ÎÀ§ °áÇÕ(ì¶Ý»êÈÌ¿ùê)
  • high-energy bond
    °í(ÍÔ)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • hydrogen bond
    ¼ö¼Ò °áÇÕ(â©áÈÌ¿ùê)
  • hydrophobic bond
    ¼Ò¼ö °áÇÕ(áÂâ©Ì¿ùê)
  • ionic bond
    À̿°áÇÕ(Ì¿ùê)
  • isoelectronic bond
    µîÀüÀÚ°áÇÕ(Ôõï³í­Ì¿ùê)
  • isologous bond
    µ¿Á¾°áÇÕ(ÔÒðúÌ¿ùê)
  • isopeptide bond
    ¾ÆÀÌ¼ÒÆéŸÀ̵å°áÇÕ(Ì¿ùê)
  • localized bond
    ±¹¼Ò°áÇÕ(ÏÑá¶Ì¿ùê)
  • lyophobic bond
    ¼Ò¾×°áÇÕ(áÃäûÌ¿ùê)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
OE on examination; order entry [system]; orofacial cleft; orthopedic examination; otitis externa; out-s...
POE pediatric orthopedic examination; physician order entry; point of entry; polyoxyethylene; postoperat...
POS periosteal osteosarcoma; physician order set; point of service; polycystic ovary syndrome; psychoorg...
RO radiation oncology; radiation output; ratio of; relative odds; renal osteodystrophy; reverse osmosis...
SOB see order blank; shortness of breath
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
hydrogen bond <chemistry> A weak electrostatic link between an electronegative atom (such asoxygen) and a hydrogen atom which is linked covalently to anotherelectronegative atom, hydrogen bonding is what makes water stick toitself.
(09 Oct 1997)
hydrophobic bond See: hydrophobic interaction.
(05 Mar 2000)
sigma bond <chemistry> A bond formed from the overlap of either two s-orbitals or two hybrid orbitals such as sp3 or sp2 orbitals.
(09 Jan 1998)
single bond A covalent bond resulting from the sharing of one pair of electrons; e.g., H3C-CH3 (ethane).
(05 Mar 2000)
noncovalent bond Bond in which electrons are not shared between atoms; e.g., electrostatic bond, hydrogen bond.
(05 Mar 2000)
sulfur-sulfur bond isomerases <enzyme> Enzymes that catalyze the transposition of a sulfur-sulfur bond.
Registry number: EC 5.3.4
(12 Dec 1998)
disulfide bond A single bond between two sulfurs; specifically, the -S-S- link binding two peptide chains (or different parts of one peptide chain); also occurs as part of the molecule of the amino acid, cystine, and is important as a structural determinant in many protein molecules, notably keratin, insulin, and oxytocin. A symmetric disulfide is R-S-S-R; R'-S-S-R is a mixed disulfide.
(05 Mar 2000)
disulphide bond <chemistry, molecular biology> The S S linkage. A linkage formed between the SH groups of two cysteine moieties either within or between peptide chains.
Each cysteine then becomes a half cystine residue. S S linkages stabilise, but do not determine, secondary structure in proteins. They are easily disrupted by SH groups in an exchange reaction and are not present in cytosolic proteins (cytosol has a high concentration of glutathione that has a free SH residue).
(18 Nov 1997)
double bond <chemistry> A covalent bond resulting from the sharing of two pairs of electrons; e.g., H2C==CH2 (ethylene).
(05 Mar 2000)
isopeptide bond An amide linkage between a carboxyl group of one amino acid and an amino group of another amino acid in which at least one of these groups is not on the a-carbon of one of the amino acids; for example, the bond between the glutamyl residue and the cysteinyl residue of glutathione.
Compare: peptide bond, eupeptide bond.
(05 Mar 2000)
electrostatic bond Bond between atoms or groups carrying opposite charges (or, in some cases, partial charges).
Synonym: heteropolar bond, salt bridge.
(05 Mar 2000)
energy-rich bond See: high energy compounds.
(05 Mar 2000)
triple bond A covalent bond resulting from the sharing of three pairs of electrons; e.g., HC&equiv;CH (acetylene).
(05 Mar 2000)
eupeptide bond A peptide bond between the alpha-carboxyl group of one amino acid and the alpha-amino group of another amino acid.
Compare: peptide bond, isopeptide bond.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • peck order
    ÂÉ´Â ¼ø¹ø
  • pecking order
    ÂÉ´Â ¼ø¹ø
  • Attic order
    ¾ÆÆ¼Ä«½Ä(°¢ÁÖ½Ä)
  • Cistercian Order
    ½ÃÅä¼öµµÈ¸(1098³â ÇÁ¶û½º¿¡¼­ â¼³)
  • Distinguished Service Order
    (¿µ±º)¼öÈÆÀå
  • Dominican Order
    µµ¹Ì´ÏÄÚ ¼öµµÈ¸(·Î¸¶ Ä«Å縯 ¼Ò¼Ó)
  • Ionic order
    (°Ç)ÀÌ¿À´Ï¾Æ ¾ç½Ä(±âµÕ¸é¿¡ flute(¼¼·ÎÈì)ÀÌ ÀÖ°í ±âµÕ¸Ó¸® ¾çÂÊ¿¡ ¼Ò¿ëµ¹ÀÌ ²ÃÀÌ ºÙÀ½)
  • Roman order
    ·Î¸¶ ÁÖ½Ä;È¥ÇÕÁÖ½Ä
  • apple pie order
    Áú¼­ÀÖÀ½;Á¤µ·;¾çÈ£»óÅÂ
  • cancel back order
    ¹ÌÁ¶´Þ ÁÖ¹®ÀÇ Ãë¼Ò
  • cease and sesist order
    (ºÎ´ç °æÀï.³ëµ¿ÇàÀ§ µî¿¡ ´ëÇÑ ÇàÁ¤±â°üÀÇ)Á¤Áö ¸í·É
  • clearance order
    °Ç¹° ö°Å ¸í·É
  • close order
    ¹ÐÁý ´ëÇü
  • court order
    ¹ý¿ø ¸í·É
  • eviction order
    Åð°Å ¸í·É
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á